Find clinical trials for Adenocarcinoma in Cincinnati, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Adenocarcinoma trials near Cincinnati, OH, USA:
for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for ...
Phase 3
Edgewood, Kentucky, United States and 197 other locations
mFOLFIRINOX alone in participants with resected pancreatic ductal adenocarcinoma (PDAC) who have not received prior systemic anti-cancer tre...
Phase 2
Cincinnati, Ohio, United States and 21 other locations
participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSignatur...
Phase 1, Phase 2
Cincinnati, Ohio, United States and 67 other locations
unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma. Why is this study being done? SPOTLIGHT is a new clinical st...
Phase 3
Middletown, Ohio, United States and 219 other locations
The purpose of this multicentric, open label trial (NAPISTAR 1-01) is to evaluate the safety/tolerability, pharmacokinetics and preliminary efficacy...
Phase 1, Phase 2
Cincinnati, Ohio, United States
and efficacy of TAC01-HER2 as a monotherapy, and in combination with pembrolizumab, in subjects with HER2 positive gastric and gastroesophageal adenocarcinoma...
Phase 1, Phase 2
Cincinnati, Ohio, United States and 10 other locations
The ProVent study is a randomized, open-label study designed to assess the efficacy of sipuleucel-T in reducing the progression of lower risk non-met...
Phase 3
Cincinnati, Ohio, United States and 55 other locations
This study is to evaluate the safety and tolerability of RMC-9805 in adults with KRAS G12D-mutant solid tumors.
Phase 1
Cincinnati, Ohio, United States and 6 other locations
This is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers.
Phase 1, Phase 2
Cincinnati, Ohio, United States and 9 other locations
Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors.
Phase 1
Cincinnati, Ohio, United States and 14 other locations
Clinical trials
Research sites
Resources
Legal